Indication

Treatment of symptomatic chronic heart failure with reduced ejection fraction.

Medicine details

Medicine name:
empagliflozin (Jardiance)
SMC ID:
SMC2396
Pharmaceutical company
Boehringer Ingelheim Ltd
BNF chapter
Cardiovascular system
Submission type
Abbreviated
Publication due date:
11 October 2021